Start-Up Spotlight: NovaSignal Aims To Commercialize Transcranial Ultrasound
With a mostly forgotten imaging modality, NovaSignal is trying to create the “fifth vital sign.” Medtech Insight spoke to chairman and chief executive officer, Diane Bryant, to learn more about the company's transcranial ultrasound technology.
You may also be interested in...
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.